跳至主要内容
临床试验/NL-OMON29982
NL-OMON29982尚未招募3 期

To study the cardiovasculair effects of vasodilatation by nifedipine (Adalat gastrointestinal therapeutic system) with or without plasma volume expansion with Voluven (colloid) in women with preeclampsia - plasmavolumeexpansion, nifedipine and preeclampsia

Academisch Medisch Centrum0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
22

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • preeclampsia, gestational age 24- 34 weeks, singleton pregnancy

排除标准

  • known allergy to nifedipine, known cardiovasculair or renal- or liverpathology, previous treatment with antihypertensives or tocolytics, foetal distress necessitating delivery in less than 48 uur, imminent eclampsia, no informed consent from the patient or the doctor treating the patient, multiple pregnancy, unable to take tablets

研究者

相似试验